Gabelli Funds LLC trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 142,300 shares of the company’s stock after selling 1,200 shares during the period. Gabelli Funds LLC’s holdings […]
Keeley Teton Advisors LLC lessened its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 9.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,395 shares of the company’s stock after selling 242 shares during the period. Keeley Teton Advisors LLC’s holdings […]
Asahi Life Asset Management CO. LTD. lifted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 182.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,865 shares of the company’s stock after purchasing an additional 3,790 shares during the quarter. […]
Asahi Life Asset Management CO. LTD. lifted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 182.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,865 shares of the company’s stock after purchasing an additional 3,790 shares during the quarter. […]
Epoch Investment Partners Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 4.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,120,133 shares of the company’s stock after selling 57,875 shares during the quarter. AbbVie accounts for approximately […]